BET1
Basic information
Region (hg38): 7:93962762-94004382
Links
Phenotypes
GenCC
Source:
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Muscular dystrophy, congenital, with rapid progression | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 34779586 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BET1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 5 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 6 | 0 | 0 |
Variants in BET1
This is a list of pathogenic ClinVar variants found in the BET1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-93994306-G-T | not specified | Uncertain significance (Oct 30, 2023) | ||
7-93994308-T-A | not specified | Uncertain significance (Jul 14, 2023) | ||
7-93994385-C-G | Progressive muscle weakness;Seizure • Muscular dystrophy, congenital, with rapid progression | Uncertain significance (Feb 25, 2019) | ||
7-93996314-A-C | Muscular dystrophy, congenital, with rapid progression | Uncertain significance (Aug 28, 2020) | ||
7-93999179-AG-A | Progressive muscle weakness;Seizure • Muscular dystrophy, congenital, with rapid progression | Uncertain significance (Feb 25, 2019) | ||
7-93999198-A-C | not specified | Uncertain significance (Jun 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BET1 | protein_coding | protein_coding | ENST00000222547 | 4 | 41621 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00383 | 0.657 | 125714 | 0 | 33 | 125747 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.216 | 52 | 56.6 | 0.919 | 0.00000240 | 768 |
Missense in Polyphen | 13 | 15.227 | 0.85376 | 218 | ||
Synonymous | 1.68 | 11 | 20.7 | 0.531 | 8.91e-7 | 218 |
Loss of Function | 0.570 | 4 | 5.43 | 0.736 | 2.26e-7 | 80 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000214 | 0.000214 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000463 | 0.0000462 |
European (Non-Finnish) | 0.000230 | 0.000229 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000401 | 0.0000327 |
Other | 0.000164 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Required for vesicular transport from the ER to the Golgi complex. Functions as a SNARE involved in the docking process of ER-derived vesicles with the cis-Golgi membrane (By similarity). {ECO:0000250}.;
- Pathway
- SNARE interactions in vesicular transport - Homo sapiens (human);miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;miR-targeted genes in squamous cell - TarBase;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;COPI-mediated anterograde transport;COPII-mediated vesicle transport;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.0904
Intolerance Scores
- loftool
- 0.698
- rvis_EVS
- -0.01
- rvis_percentile_EVS
- 52.85
Haploinsufficiency Scores
- pHI
- 0.0625
- hipred
- Y
- hipred_score
- 0.513
- ghis
- 0.597
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.533
Mouse Genome Informatics
- Gene name
- Bet1
- Phenotype
Gene ontology
- Biological process
- endoplasmic reticulum to Golgi vesicle-mediated transport;protein transport;COPII vesicle coating;vesicle fusion with Golgi apparatus
- Cellular component
- Golgi trans cisterna;Golgi membrane;endoplasmic reticulum membrane;membrane;transport vesicle;integral component of Golgi membrane;SNARE complex;endoplasmic reticulum-Golgi intermediate compartment membrane
- Molecular function
- SNAP receptor activity;protein binding